Your browser doesn't support javascript.
loading
Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.
Doores, Katie J; Kong, Leopold; Krumm, Stefanie A; Le, Khoa M; Sok, Devin; Laserson, Uri; Garces, Fernando; Poignard, Pascal; Wilson, Ian A; Burton, Dennis R.
  • Doores KJ; Department of Infectious Diseases, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom katie.doores@kcl.ac.uk burton@scripps.edu.
  • Kong L; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research
  • Krumm SA; Department of Infectious Diseases, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.
  • Le KM; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jo
  • Sok D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jo
  • Laserson U; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA.
  • Garces F; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research
  • Poignard P; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.
  • Wilson IA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research
  • Burton DR; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jo
J Virol ; 89(2): 1105-18, 2015 Jan 15.
Article en En | MEDLINE | ID: mdl-25378488
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article